Implantation of venous access devices under local anesthesia: patients' satisfaction with oral lorazepam

De-Hua Chang, Sonja Hiss, Lena Herich, Ingrid Becker, Kamal Mammadov, Mareike Franke, Anastasios Mpotsaris, Robert Kleinert, Thorsten Persigehl, David Maintz, Christopher Bangard, De-Hua Chang, Sonja Hiss, Lena Herich, Ingrid Becker, Kamal Mammadov, Mareike Franke, Anastasios Mpotsaris, Robert Kleinert, Thorsten Persigehl, David Maintz, Christopher Bangard

Abstract

Objective: The aim of the study reported here was to evaluate patients' satisfaction with implantation of venous access devices under local anesthesia (LA) with and without additional oral sedation.

Materials and methods: A total of 77 patients were enrolled in the prospective descriptive study over a period of 6 months. Subcutaneous implantable venous access devices through the subclavian vein were routinely implanted under LA. Patients were offered an additional oral sedative (lorazepam) before each procedure. The level of anxiety/tension, the intensity of pain, and patients' satisfaction were evaluated before and immediately after the procedure using a visual analog scale (ranging from 0 to 10) with a standardized questionnaire.

Results: Patients' satisfaction with the procedure was high (mean: 1.3±2.0) with no significant difference between the group with premedication and the group with LA alone (P=0.54). However, seven out of 30 patients (23.3%) in the group that received premedication would not undergo the same procedure without general anesthesia. There was no significant influence of lorazepam on the intensity of pain (P=0.88). In 12 out of 30 patients (40%) in the premedication group, the level of tension was higher than 5 on the visual analog scale during the procedure. In 21 out of 77 patients (27.3%), the estimate of the level of tension differed between the interventionist and the patient by 3 or more points in 21 out of 77 patients (27.3%).

Conclusion: Overall patient satisfaction is high for implantation of venous access devices under LA. A combination of LA with lorazepam administered orally might not be adequate for patients with a high level of anxiety and tension. The level of tension is often underestimated by the interventionist. Pre-procedural standardized questionnaires could be used to identify patients for whom a gradual approach of individualized sedation may be more effective.

Keywords: central venous port implantation; chemotherapy; pain; patient satisfaction; supportive care.

Figures

Figure 1
Figure 1
Difference in tension before intervention and during intervention, with and without premedication. Notes: Patients were categorized in three groups depending on the tension level before the intervention (low: 0–3; medium: 4–7; high: 8–10). N is the number of patients; “No” indicates patients without premedication; “Yes” indicates patients with premedication. The short dashes within the boxes indicate the mean, and the broad lines indicate the median. Tension is measured by visual analog scale (VAS; 0–10). The circle indicates outlier (>1.5× IQR).
Figure 2
Figure 2
Patients’ self-assessment of the level of tension compared with the estimation by the physician (with and without premedication, VAS; 0–10). Abbreviation: VAS, visual analog scale.
Figure 3
Figure 3
Patients’ satisfaction (VAS 0–10) in respect of the grade of tension (VAS ≤5/10 or >5/10) with and without premedication. Notes: The circle indicates outlier (>1.5× IQR); the star indicates far outlier (>3× IQR). Abbreviations: IQR, interquartile range; VAS, visual analog scale.
Figure 4
Figure 4
Intensity of pain during the procedure (VAS; 0–10) with and without premedication. Notes: The circles indicate outlier (>1.5× IQR); the star indicates far outlier (>3× IQR). Abbreviations: IQR, interquartile range; VAS, visual analog scale.

References

    1. Chang DH, Kabbasch C, Bovenschulte H, Libicher M, Maintz D, Bangard C. Experiences with power-injectable port systems: complications, patient satisfaction and clinical benefit. Rofo. 2013;185(5):454–460.
    1. Quinn RR, Lamping DL, Lok CE, et al. The Vascular Access Questionnaire: assessing patient-reported views of vascular access. J Vasc Access. 2008;9(2):122–128.
    1. Jung M, Hofmann C, Kiesslich R, Brackertz A. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam. Endoscopy. 2000;32(3):233–238.
    1. Wang D, Chen C, Chen J, et al. The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS One. 2013;8(1):e53311.
    1. Van Aken H, Biermann E, Martin J, et al. Analgosedierung für diagnostische und therapeutische Maßnahmen bei Erwachsenen [Sedation for diagnostic and therapeutic procedures in adults] Anästhesiologie und Intensivmedizin. 2010;51:S598–S602. German.
    1. Millar K, Jelicic M, Bonke B, Asbury AJ. Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. Br J Anaesth. 1995;74(2):180–183.
    1. Watmough S, Flynn M. A review of pain management interventions in bone marrow biopsy. J Clin Nurs. 2011;20(5–6):615–623.
    1. Maurer MH, Beck A, Hamm B, et al. Central venous port catheters: evaluation of patients’ satisfaction with implantation under local anesthesia. J Vasc Access. 2009;10(1):27–32.
    1. Giannoutsos I, Grech H, Maboreke T, Morgenstern G. Performing bone marrow biopsies with or without sedation: a comparison. Clin Lab Haematol. 2004;26(3):201–204.
    1. Milligan DW, Howard MR, Judd A. Premedication with lorazepam before bone marrow biopsy. J Clin Pathol. 1987;40(6):696–698.
    1. Hjortholm N, Jaddini E, Hałaburda K, Snarski E. Strategies of pain reduction during the bone marrow biopsy. Ann Hematol. 2013;92(2):145–149.
    1. Kramskay R, Tansky A, Eisenberg E, Veitsman E, Baruch Y. Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study. Eur J Gastroenterol Hepatol. 2011;23(9):782–786.
    1. Lenhart M, Schätzler S, Manke C, et al. Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients. Rofo. 2010;182(1):20–28. German.
    1. Povoski SP. A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients. Ann Surg Oncol. 2000;7(7):496–502.
    1. Paoletti F, Ripani U, Antonelli M, Nicoletta G. Central venous catheters. Observations on the implantation technique and its complications. Minerva Anestesiol. 2005;71(9):555–560.

Source: PubMed

3
Tilaa